Evidence map›Paper›PMID 22408253›Full record

ArticleThe Journal of biological chemistry2012

Functional and structural analysis of the siderophore synthetase AsbB through reconstitution of the petrobactin biosynthetic pathway from Bacillus anthracis.

Tyler D Nusca, Youngchang Kim, Natalia Maltseva, Jung Yeop Lee, William Eschenfeldt, Lucy Stols, Michael M Schofield, Jamie B Scaglione, Shandee D Dixon, Daniel Oves-Costales and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 49 citations in OpenAlex.

  1. A frameshift mutation drives divergent biosynthesis of metallophores inbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Whole-Genome Analysis ofMicroorganisms · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. The Purified Siderophore fromMolecules (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Tyler D NuscaLife Sciences Institute, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Youngchang Kim
Natalia Maltseva
Jung Yeop Lee
William Eschenfeldt
Lucy Stols
Michael M Schofield
Jamie B Scaglione
Shandee D Dixon
Daniel Oves-Costales
Gregory L Challis
Philip C Hanna
Brian F Pfleger
Andrzej Joachimiak
David H Sherman
University of Michigan · USArgonne National Laboratory · USUniversity of Warwick · GBUniversity of Wisconsin–Madison · US

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI SHUMAN, HOWARD A · 2003 to 2013
$87.6M
The Midwest Center for Structural GenomicsU54GM074942 · NIGMS · UNIVERSITY OF CHICAGO · PI JOACHIMIAK, ANDRZEJ · 2005 to 2009
$51.0M
Midwest Center for Structural GenomicsU54GM094585 · NIGMS · UNIVERSITY OF CHICAGO · PI MINOR, WLADEK · 2010 to 2014
$33.7M
Cellular Biotechnology Training Program (CBTP)T32GM008353 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHWENDEMAN, ANNA · 1991 to 2021
$9.3M
Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
Biotechnology and Biological Sciences Research Council BB/F013760/1NIAID NIH HHS U54 AI057153NIAID NIH HHS U54-AI-057153NIGMS NIH HHS GM074942NIGMS NIH HHS T32 GM008353NIGMS NIH HHS T32 GM145304NIGMS NIH HHS U54 GM074942NIGMS NIH HHS U54 GM094585
6 · The paper itself

Abstract

Petrobactin, a mixed catechol-carboxylate siderophore, is required for full virulence of Bacillus anthracis, the causative agent of anthrax. The asbABCDEF operon encodes the biosynthetic machinery for this secondary metabolite. Here, we show that the function of five gene products encoded by the asb operon is necessary and sufficient for conversion of endogenous precursors to petrobactin using an in vitro system. In this pathway, the siderophore synthetase AsbB catalyzes formation of amide bonds crucial for petrobactin assembly through use of biosynthetic intermediates, as opposed to primary metabolites, as carboxylate donors. In solving the crystal structure of the B. anthracis siderophore biosynthesis protein B (AsbB), we disclose a three-dimensional model of a nonribosomal peptide synthetase-independent siderophore (NIS) synthetase. Structural characteristics provide new insight into how this bifunctional condensing enzyme can bind and adenylate multiple citrate-containing substrates followed by incorporation of both natural and unnatural polyamine nucleophiles. This activity enables formation of multiple end-stage products leading to final assembly of petrobactin. Subsequent enzymatic assays with the nonribosomal peptide synthetase-like AsbC, AsbD, and AsbE polypeptides show that the alternative products of AsbB are further converted to petrobactin, verifying previously proposed convergent routes to formation of this siderophore. These studies identify potential therapeutic targets to halt deadly infections caused by B. anthracis and other pathogenic bacteria and suggest new avenues for the chemoenzymatic synthesis of novel compounds.

Indexed as

Biosynthetic PathwaysAmino Acid SequenceBacillus anthracisBacterial ProteinsBenzamidesBiocatalysisCarbon-Nitrogen LigasesCrystallography, X-RayLigasesModels, ChemicalModels, MolecularMolecular Sequence DataMolecular StructurePolyaminesProtein BindingProtein Structure, TertiaryBacterial ProteinsBenzamidesCarbon-Nitrogen LigasesLigasespetrobactinPolyaminesSiderophores

Identifiers

PMID22408253
PMCPMC3346087
OpenAlexW2049910813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.